Physician Assistant · Winter Haven, FL
NPI
1386880771
Since 2009
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
429 2nd St NW
Winter Haven, FL, 33881
Phone (813) 321-1786
Groups this clinician bills Medicare through
Medicare paid, 2024
$65K
1,953 services
Medicare patients, 2024
217
Average age 74
Drug cost, 2024
$1.0M
2,698 prescriptions
Company payments, 2025
$2,462
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Amy R Strohmaier was code 17003 (destruction skin lesion), 871 times for 113 patients. In total Amy R Strohmaier billed 1,953 services in 36 codes, and Medicare paid $65K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-01-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 871 | 113 | $3.86 | $3,359 |
| 99213 Office E&M - Established | Office | 256 | 156 | $49.19 | $13K |
| 17000 Destruction Skin Lesion | Office | 207 | 133 | $27.91 | $5,777 |
| 17110 Destruction Skin Lesion | Office | 136 | 101 | $65.61 | $8,923 |
| 11102 Skin Biopsy | Office | 125 | 95 | $48.66 | $6,082 |
| 17004 Destruction Skin Lesion | Office | 78 | 43 | $95.23 | $7,428 |
| 99214 Office E&M - Established | Office | 77 | 62 | $77.14 | $5,939 |
| 11103 Skin Biopsy | Office | 45 | 27 | $30.51 | $1,373 |
| 99203 Office E&M - New | Office | 30 | 30 | $54.35 | $1,631 |
| 99212 Office E&M - Established | Office | 19 | 13 | $32.77 | $623 |
| 17111 Destruction Skin Lesion | Office | 17 | 11 | $75.77 | $1,288 |
| 99204 Office E&M - New | Office | 16 | 16 | $77.16 | $1,235 |
| 12032 Wound Repair - All Levels | Office | 14 | 14 | $199.08 | $2,787 |
By year: 2022 $50K for 1,538 services; 2023 $55K for 1,738 services; 2024 $65K for 1,953 services.
Medicare prescription drug claims, 2024
In 2024, the drug Amy R Strohmaier prescribed most often to Medicare patients was Ketoconazole, with 443 prescriptions and refills. In total Amy R Strohmaier wrote 2,698 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ketoconazole Generic | 443 | 475 | 182 | $6,999 |
| Triamcinolone Acetonide Generic | 272 | 308 | 167 | $2,323 |
| Levocetirizine Dihydrochloride Generic | 266 | 521 | 103 | $3,603 |
| Hydrocortisone Generic | 263 | 278 | 138 | $1,285 |
| Clobetasol Propionate Generic | 203 | 214 | 117 | $7,496 |
| Doxycycline Hyclate Generic | 195 | 209 | 104 | $3,255 |
| Fluocinolone Acetonide Generic | 143 | 148 | 64 | $8,410 |
| Mupirocin Generic | 131 | 131 | 103 | $934 |
| Ammonium Lactate Generic | 117 | 155 | 45 | $2,847 |
| Dupixent Pen Dupilumab | 110 | 110 | 14 | $429K |
| Clindamycin Phosphate Generic | 61 | 64 | 28 | $1,191 |
| Hydroxyzine Hcl Generic | 39 | 49 | 18 | $423 |
| Tretinoin Generic | 34 | 35 | 15 | $1,791 |
| Metronidazole Generic | 27 | 32 | 18 | $1,293 |
| Betamethasone Dipropionate Generic | 26 | 27 | 11 | $1,139 |
Brand drugs: 200 claims; generic drugs: 2,498 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Amy R Strohmaier $2,462 ($2,462 in general payments such as food, travel and fees) from 9 companies. The largest payer was Janssen Biotech, Inc. with $1,528.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 11 | $1,528 |
| Regeneron Healthcare Solutions, Inc. REGN | 9 | $394 |
| Pfizer Inc. PFE | 6 | $179 |
| Abbvie Inc. ABBV | 9 | $157 |
| Genzyme Corporation SNY | 3 | $67.85 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $52.52 |
| Galderma Laboratories, L.P. GALD.SW | 2 | $43.03 |
| Organon LLC OGN | 2 | $26.75 |
| Incyte Corporation INCY | 1 | $13.72 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.